
About this episode
Kindbody was once one of the fastest-growing fertility chains in the US. The venture-backed company cultivated a modern and millennial-friendly aesthetic that helped it attract more than $300 million in investments, including backing from celebrity investors like Gwyneth Paltrow and Chelsea Clinton. But Kindbody has been riddled with clinical problems, with embryos being mislabeled, lost or accidentally destroyed, and has spiraled into crisis. As more people seek fertility treatment than ever, the startup's story illustrates the dangers of moving fast in a largely unregulated industry.
See omnystudio.com/listener for privacy information.
Get every episode summarized
Each time Bloomberg Tech publishes, we email you a written briefing from the transcript — the topics, who appeared, and any specific claims, with the ad reads skipped.
Email me new episodesFree for 3 shows. No card needed.
Hosts & guests
No transcript yet
This episode has not been transcribed. Request it and it moves to the front of the queue.
More episodes
More from Bloomberg Tech

Apple’s Ternus Era Starts the iPhone Duo
Bloomberg Tech

Apple Kicks Off Terns Era with First Foldable Phone
Bloomberg Tech

Qualcomm Signs Deal to Provide Amazon With Custom AI Chips
Bloomberg Tech

Anthropic Builds Its War Chest Ahead of IPO
Bloomberg Tech